论文信息 - A phase III randomized, doúble‐blind, multiinstitutional trial of vaccinia melanoma oncolysate‐active specific immunotherapy for patients with stage II melanoma - 字舞流文

A phase III randomized, doúble‐blind, multiinstitutional trial of vaccinia melanoma oncolysate‐active specific immunotherapy for patients with stage II melanoma

K. Bland | C. Balch | A. Bartolucci | M. Wallack | M. Urist | D. Murray | J. Richards | W. Robinson | L. Flaherty | M. Sivanandham | L. Rosen